# Gergely Ivancsics

> Gergely Ivancsics is a seed investor at Impact Ventures Hungary backing Health Care and Software. See 8 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Impact Ventures Hungary](https://shizune.co/investors/profile/impact-ventures-hungary)
- Total investments: 8
- Last investment: Sep 2025
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/gergely-ivancsics-74831966/

Gergely Ivancsics is a seed investor at Impact Ventures Hungary focused on Health Care and Software. Gergely Ivancsics currently works as the Founder and Senior Investment Manager for Impact Ventures Hungary. He previously worked at PBG FMC Venture Capital Fund Management Ltd. as an Investment Analyst. Gergely Ivancsics attended CEMS - The Global Alliance in Management Education in 2017.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 38% |
| Software | 2 | 25% |
| Manufacturing | 2 | 25% |
| Nanotechnology | 2 | 25% |
| Apps | 1 | 13% |

17 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 63% |
| Series A | 1 | 13% |
| Venture - Series Unknown | 1 | 13% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Latvia | 2 | 25% |
| Poland | 1 | 13% |
| Czech Republic | 1 | 13% |
| United Kingdom | 1 | 13% |
| The Netherlands | 1 | 13% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Doctor.One | Doctor.One is a chronic care platform that empowers healthcare professionals to stay connected with their patients through continuous, asynchronous communication. By transforming care into a relationship-driven experience beyond the visit, we help improve engagement, boost adherence, and ensure that no chronic patient feels alone in their healthjourney. | $4.7M | Seed | Sep 17, 2025 |  |
| Prosoma | Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life. |  | Series A | Jun 16, 2025 |  |
| Prosoma | Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life. | $4.6M | Seed | Jan 20, 2025 |  |
| Naco | Naco builds a manufacturing station to provide its clients with ready-to-use coated parts for hydrogen production. | $2.6M | Seed | Jan 14, 2025 |  |
| Naco Technologies | Naco Technologies Ltd develops, manufactures, and supplies nano coating technologies to customers worldwide.The company provides a range of high-performance multilayer and multicomponent coatings for equipment used in the tooling, automotive, aerospace, and micro-chip industries. Its products include oil-enhanced, wear-protective, thermalbarrier, and liquid-repellent coatings.Naco Technologies was founded in 2009 and is based in Riga, Latvia. In 2015 Naco Texhnologies was acquired by the Germany-based Schaeffler Group. | $1.3M | Venture - Series Unknown | Dec 21, 2023 |  |
| Naco | Naco builds a manufacturing station to provide its clients with ready-to-use coated parts for hydrogen production. | $1.3M | Seed | Dec 20, 2023 |  |
| Hedepy | Hedepy is a health app that provides psychotherapy for everyone through video calls and is accessible, easy, and prejudice-free. | $1.9M | Seed | Dec 01, 2023 |  |
| Envision | Envision speaks out the visual world for the blind and low-vision users. It combines the best of assistive technology and artificial intelligence to bring the experience of independence to the visually impaired. | $1.8M | Seed | May 18, 2021 |  |

8 of 8 investments shown.

## Co-investors
- [The Untitled Venture Company](https://shizune.co/investors/profile/the-untitled-venture-company) — VC Fund, 3 deals together
- [4impact](https://shizune.co/investors/profile/4impact) — VC Fund, 2 deals together
- [Smartlink Partners](https://shizune.co/investors/profile/smartlink-partners) — VC Fund, 2 deals together
- [Verge HealthTech Fund](https://shizune.co/investors/profile/verge-healthtech-fund) — VC Fund, 2 deals together
- [ABN AMRO Fund](https://shizune.co/investors/profile/abn-amro) — VC Fund, 1 deal together
- [Aligo Venture Capital](https://shizune.co/investors/profile/aligo-venture-capital) — VC Fund, 1 deal together

## About Impact Ventures Hungary

VC Fund · Budapest, Hungary

Impact Ventures is a specialist fund manager focusing on Impact Investments. Our mission is to catalyze social impact by supporting and investing in high-growth social SMEs in Europe, addressing areas of social inclusion, education, employment, health and environmental sustainability.

1 contacts available at Impact Ventures Hungary.

| Name | Title | Profile |
| --- | --- | --- |
| Gergely Ivancsics | Founder and Senior Investment Manager | https://shizune.co/investors/profile/gergely-ivancsics |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Gergely Ivancsics invest in?

Gergely Ivancsics invests primarily in Health Care, Software and Manufacturing startups, most often at Seed and Series A stage. Most of the 8 investments tracked by Shizune back companies in Latvia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Gergely Ivancsics last invest?

The most recent investment recorded for Gergely Ivancsics closed in Sep 2025. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co